Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin saline versus normal saline for maintaining peripheral intravenous catheter patency in cancer patients
IRCT20190325043107N4Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jun 2019
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of heparin and sodium chloride in phlebitis (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Phlebitis. Started Jun 2019; status: completed.
02
Drugs
heparinsodium chloride
03
Conditions
phlebitis
Beyond the preview
Go deeper on IRCT20190325043107N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190325043107N4.